PMID- 38370106
OWN - NLM
STAT- MEDLINE
DCOM- 20240220
LR  - 20240420
IS  - 1937-8688 (Electronic)
VI  - 45
IP  - Suppl 2
DP  - 2023
TI  - Providing information for decision-making in the Nigerian Polio Eradication 
      Program, 2016-2020.
PG  - 11
LID - 10.11604/pamj.supp.2023.45.2.39489 [doi]
LID - 11
AB  - Nigeria made a coordinated effort to be certified by the World Health 
      Organization's African Region for interrupting endemic transmission of wild 
      poliovirus type-1 (WPV1) in August 2020 as a response to the resurgence of WPV1 
      cases in August 2016 after going two years without a case. The NEOC Data Working 
      Group (DWG) was instrumental in providing quality and timely surveillance and 
      campaign information for decision-making in order to interrupt WPV1 transmission 
      and provide data toward documentation of its elimination for regional 
      certification. The polio pre-campaign dashboard was used to assess the level of 
      preparedness for Oral Poliovirus Vaccine (OPV) polio supplementary immunization 
      activities (SIA) at three weeks, two weeks, one week, and three days to the start 
      of each campaign implemented during 2016-2020. The administrative tally sheet, 
      independent monitoring survey, and Lot Quality Assurance Sampling (LQAS) survey 
      data collected and shared from the implementation level were analyzed by the EOC 
      DWG to provide information by person, place, and time. Using a 90% threshold in 
      LQAS surveys defining quality SIAs, the proportion of Local Government Areas 
      (LGAs) in Nigeria's states in which post-SIA LQAS surveys were conducted that met 
      this threshold were assessed over time. The highest level of preparedness 
      attained by 3 days to a polio campaign during August 2016-February 2020 was 95% 
      and the lowest attained was 77%. The admin, independent monitoring, and LQAS data 
      analysis results were given to EOC working groups for assessing the performance 
      and quality of each campaign. Twenty-twenty five percent of LGAs that failed LQAS 
      were identified for repeat vaccination. Further, acute flaccid paralysis and 
      environmental surveillance data and laboratory results were analyzed and shared 
      with NEOC and partners. The government and partners used the information 
      generated by the Data Working Group to take evidence-based action including 
      determining the scope of the polio campaign, intensification of surveillance and 
      routine immunization activities, and special intervention activities. On average, 
      12% of the 774 LGAs were identified as polio high risk LGAs for intervention 
      using selected surveillance, routine immunization (RI), SIAs, and other relevant 
      data sets. National Emergency Operation Centre Data Working Group provided 
      quality and timely information that supported decision-making processes for the 
      polio program in Nigeria. The quality and timely information enabled the NEOC to 
      make evidence-based and timely decisions that contributed to gap identification 
      and decision-making.
CI  - (c)Tesfaye Erbeto et al.
FAU - Erbeto, Tesfaye
AU  - Erbeto T
AD  - World Health Organization Country Office, Abuja, Nigeria.
FAU - Bammeke, Philip
AU  - Bammeke P
AD  - Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
FAU - Aregay, Aron
AU  - Aregay A
AD  - World Health Organization Country Office, Abuja, Nigeria.
FAU - Kamran, Zabihullah
AU  - Kamran Z
AD  - United Nations Children's Fund Nigeria Country Office, Copenhagen, Denmark.
FAU - Ibrahim, Ahmed
AU  - Ibrahim A
AD  - World Health Organization Country Office, Abuja, Nigeria.
FAU - Usifoh, Nnamdi
AU  - Usifoh N
AD  - African Field Epidemiology Network, Abuja, Nigeria.
FAU - Adamu, Usman
AU  - Adamu U
AD  - National Primary Healthcare Development Agency, Abuja, Nigeria.
AD  - National Emergency Operation Centre, Abuja, Nigeria.
FAU - Omotayo, Bolu
AU  - Omotayo B
AD  - Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
FAU - Braka, Fiona
AU  - Braka F
AD  - World Health Organization Country Office, Abuja, Nigeria.
FAU - Damisa, Eunice
AU  - Damisa E
AD  - National Primary Healthcare Development Agency, Abuja, Nigeria.
FAU - Kazadi, Walter
AU  - Kazadi W
AD  - World Health Organization Country Office, Abuja, Nigeria.
FAU - Shuaib, Faisal
AU  - Shuaib F
AD  - National Primary Healthcare Development Agency, Abuja, Nigeria.
LA  - eng
GR  - 001/WHO_/World Health Organization/International
PT  - Journal Article
PT  - Review
DEP - 20230907
PL  - Uganda
TA  - Pan Afr Med J
JT  - The Pan African medical journal
JID - 101517926
RN  - 0 (Poliovirus Vaccine, Oral)
SB  - IM
MH  - Humans
MH  - Lot Quality Assurance Sampling
MH  - Disease Eradication/methods
MH  - *Poliomyelitis/epidemiology/prevention & control
MH  - *Poliovirus
MH  - Poliovirus Vaccine, Oral
MH  - Nigeria/epidemiology
MH  - Immunization Programs
PMC - PMC10874091
OTO - NOTNLM
OT  - Vaccination campaign
OT  - dashboard
OT  - decision-making
OT  - information
OT  - local government areas
OT  - monitoring
OT  - polio
OT  - surveillance
COIS- The authors declare no competing interests.
EDAT- 2024/02/19 06:43
MHDA- 2024/02/20 11:57
PMCR- 2023/09/07
CRDT- 2024/02/19 04:06
PHST- 2023/03/01 00:00 [received]
PHST- 2023/09/07 00:00 [accepted]
PHST- 2024/02/20 11:57 [medline]
PHST- 2024/02/19 06:43 [pubmed]
PHST- 2024/02/19 04:06 [entrez]
PHST- 2023/09/07 00:00 [pmc-release]
AID - PAMJ-45-11 [pii]
AID - 10.11604/pamj.supp.2023.45.2.39489 [doi]
PST - epublish
SO  - Pan Afr Med J. 2023 Sep 7;45(Suppl 2):11. doi: 
      10.11604/pamj.supp.2023.45.2.39489. eCollection 2023.